2012
DOI: 10.1111/j.1399-3062.2012.00752.x
|View full text |Cite
|
Sign up to set email alerts
|

Highly resistant bacteria and donor‐derived infections: treading in uncharted territory

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
17
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 36 publications
(19 citation statements)
references
References 34 publications
2
17
0
Order By: Relevance
“…Moreover, due to miscommunication, patient 2B received only 3 days of full antibiotic treatment, and developed infection. Similar to other reports, our study highlights the importance of intra-and inter-institutional communication and cooperation (2,15,17).…”
Section: Casesupporting
confidence: 91%
See 1 more Smart Citation
“…Moreover, due to miscommunication, patient 2B received only 3 days of full antibiotic treatment, and developed infection. Similar to other reports, our study highlights the importance of intra-and inter-institutional communication and cooperation (2,15,17).…”
Section: Casesupporting
confidence: 91%
“…CRE are the source of outbreaks and can be highly lethal, with a mortality rate of 40% in SOT recipients (14). There are few reports available on the optimal evaluation and management of these highly resistant bacteria in SOT donors and recipients (15)(16)(17)(18)(19)(20). In Italy, donors with bacteremia caused by carbapenemresistant gram-negative (CRGN) bacteria are routinely excluded for any organ donation.…”
Section: Introductionmentioning
confidence: 99%
“…However, available guidelines do not describe risk-stratification related to transmission of bacterial infections from donors with endocarditis. Although successful use of organs from donors with subacute bacterial endocarditis without evidence of distant septic emboli has been reported (3,4), recent reports have described increased recipient morbidity and mortality associated with transmission of multidrug-resistant organisms (MDROs) (57). Potential donor-derived disease transmission events are reported to the Organ Procurement and Transplantation Network (OPTN) per policy and reviewed by the ad hoc OPTN Disease Transmission Advisory Committee (DTAC) which categorizes each as to the likelihood of disease transmission.…”
Section: Introductionmentioning
confidence: 99%
“…Some authors suggest that targeted antimicrobial treatment following transplantation can prevent transmission of MDR gram‐negative bacteria, although it has been reported that donor‐derived bacteremia can occur despite antibiotic prophylaxis . Other authors have proposed a course of at least 14 days of antibiotics in recipients of organs with positive donor cultures, whereas others conclude that it is not necessary to treat the recipient of an allograft from a donor with non‐bacteremic, localized infection that does not involve the transplanted organ, although prophylaxis should be adequate. It would seem prudent to recommend treatment or at least close monitoring of the recipient of an allograft from a donor with non‐bacteremic infection caused by MDR bacteria.…”
Section: Discussionmentioning
confidence: 99%